Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.56 USD | +0.80% | -27.59% | +85.29% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.67B |
---|---|---|---|---|---|
Net income 2024 * | -266M | Net income 2025 * | -277M | EV / Sales 2024 * | - |
Net cash position 2024 * | 331M | Net cash position 2025 * | 364M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.3
x | P/E ratio 2025 * |
-6.74
x | Employees | 328 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.37% |
Latest transcript on Sana Biotechnology, Inc.
1 day | +0.80% | ||
1 week | -27.59% | ||
Current month | -16.00% | ||
1 month | -19.23% | ||
3 months | +16.85% | ||
6 months | +124.33% | ||
Current year | +85.29% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Harr
FOU | Founder | 53 | 18-07-12 |
Nathan Hardy
DFI | Director of Finance/CFO | 48 | 18-08-31 |
Gary Meininger
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 20-04-30 | |
Patrick Yang
BRD | Director/Board Member | 75 | 18-09-30 |
Robert Nelsen
FOU | Founder | 60 | 18-07-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 7.56 | +0.80% | 3,844,896 |
24-05-09 | 7.5 | -20.97% | 5,695,358 |
24-05-08 | 9.49 | -5.48% | 1,254,556 |
24-05-07 | 10.04 | +0.40% | 850,431 |
24-05-06 | 10 | -4.21% | 1,733,286 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+85.29% | 1.67B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- SANA Stock